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Objectives. We tested whether acute coronary occlusion inter-
feres with arterial baroreceptor control of heart rate in humans.
Background. Subnormal baroreflex sensitivity (BRS) is an
important risk indicator for sudden death. Animal research
indicates that both chronic myocardial infarction and acute
coronary occlusion impair baroreflex modulation of heart rate.
Methods. We measured RR interval prolongation after
phenylephrine-induced systolic pressure increases before and
during 2-min coronary occlusions in 47 patients (27 men) under-
going clinically indicated single-vessel coronary angioplasty for
stenoses in the proximal or midportion of the vessel causing
>50% reduction in the arterial diameter, with normal antegrade
flow (33 anterior descending, 10 circumflex, 4 right coronary
artery). A control group of 11 patients treated for chronic total
occlusion of a coronary artery was assessed to evaluate nonspe-
cific changes in baroreflex function during a 2-min balloon
inflation in the occluded artery.
Results. The BRS decreased from 5.2 6 3.8 (mean 6 SD) to
4.1 6 3.5 mszmm Hg21 (p 5 0.01) during the coronary occlusion
in the 28 patients with preserved arterial baroreceptor control of
heart rate—that is, adequate blood pressure responses and
correlation coefficients of the slopes both in baseline and during
coronary occlusion. The same phenylephrine dose increased sys-
tolic pressure less during than before coronary artery occlusion
(21 6 21 versus 36 6 16 mm Hg, p < 0.0001), and in 6 patients it
failed to prevent systolic pressure reduction during occlusion.
Correlation coefficients of the baroreflex regressions decreased
from 0.81 6 0.27 to 0.47 6 0.44 (p < 0.0001) during coronary
artery occlusion in the 41 patients with adequate systolic pressure
rises in both phenylephrine tests, and the association between RR
intervals and rising systolic pressures was lost in 13 patients
during coronary occlusion. Balloon inflation in a chronic total
occlusion of a coronary artery did not cause significant changes in
BRS (from 5.3 6 4.0 to 5.2 6 3.7 mszmm Hg21), correlation
coefficient of the slope or phenylephrine-induced pressure rise.
Conclusions. Our study shows that abrupt coronary occlusion
impairs baroreflex modulation of vagal and sympathetic nervous
outflow in humans.
(J Am Coll Cardiol 1998;32:1641–7)
©1998 by the American College of Cardiology
Animal studies suggest that arterial baroreflex control of heart
rate and vascular resistance is impaired during acute myocar-
dial ischemia (1–5). Impairment of the baroreceptor-heart rate
control has also been observed in humans after myocardial
infarction and during episodes of myocardial ischemia (6–9).
Acute coronary occlusion may cause a wide range of auto-
nomic reactions as evidenced by changes in heart rate, blood
pressure and heart rate variability (10–12), but there are
limited data on potential changes of human arterial baroreflex
function during acute coronary occlusion. Because abrupt
occlusion of a coronary artery is a major cause of sudden
cardiac death (13) and experimental studies suggest that low
baroreflex sensitivity (BRS) is a marker of increased risk of
ventricular fibrillation during acute coronary occlusion (14–
16), we assessed the effects of acute coronary occlusion on
baroreflex control of the circulation in a prospective series of
patients undergoing clinically indicated coronary angioplasty.
Methods
Study population. The study population comprised 47 con-
secutive patients (27 men) fulfilling the following criteria: 1)
single-vessel coronary angioplasty; 2) stenosis in the proximal
or midportion of the vessel causing .50% reduction in the
arterial diameter with normal antegrade flow (Thrombolysis in
Myocardial Infarction [TIMI] grade 3 flow) (17); 3) docu-
mented myocardial ischemia; 4) no history of acute myocardial
infarction and no or minimal wall motion abnormality in the
myocardial territory at risk; 5) sinus rhythm and no bundle
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branch block; 6) tolerance to .60-s coronary occlusion; 7) no
acute procedural complications; and 8) informed consent of
the patient. The clinical characteristics of the study population
are described in Table 1.
A control group of 11 patients (6 men, mean age 55 years)
treated for a chronic total occlusion (TIMI grade 0 or 1 flow)
of a coronary artery (5 left anterior descending, 1 left circum-
flex and 5 right coronary artery) was assessed to evaluate
potential nonspecific changes in baroreflex function during a
2-min balloon inflation in the occluded artery.
Study protocol. The design was approved by the Ethical
Committee of the institution and all patients gave their in-
formed consent. Coronary angioplasty was performed by a
usual technique (18). Diazepam 5–10 mg was given as premed-
ication. Sublingual nitroglycerin was given before the guiding
catheter was placed in the coronary ostium and every 15 min
thereafter. None of the patients were given atropine. In cases
of tight coronary artery stenosis, the deflated balloon, or even
the guide wire, may compromise blood flow in the vessel, so
that observations made before and during the first balloon
inflation may be inconsistent and unreliable. Thus, an initial
short balloon angioplasty (#20 s) was performed as soon as
possible after introduction of the balloon into the stenosis.
Normal coronary flow was ascertained with a contrast medium
injection after this predilatation.
Two successive balloon inflations with similar inflation
pressures (4–8 bars) and duration were performed at 5-min
intervals. These inflations, which were used for data acquisi-
tion, were designed to last up to 120 s, unless intolerable chest
pain, hemodynamic instability or ventricular ectopy necessi-
tated earlier deflation of the balloon (19). The purpose of the
first balloon inflation was to evaluate ischemia-induced hemo-
dynamic reactions (12,18) and to ensure tolerance of each
patient for at least 60 s of coronary occlusion. Based on the
information derived from the first occlusion, a phenylephrine
bolus was given during the second balloon inflation, about 60 s
before the estimated end of the occlusion. No contrast medium
was injected during data acquisition, and every effort was made
to keep the patients unaware of the timing of the balloon
inflations and to maintain the circumstances as stable as
possible so as to minimize the effects of nonspecific distress on
heart rate or blood pressure.
Patients were accustomed to breathing at a constant rate of
;0.25 Hz from the beginning of the catheterization and were
advised to avoid unnecessary talking, especially just before or
during data acquisition. In cases of intolerable chest pain
during this phase of the procedure the patients were advised to
give a hand signal and the balloon was deflated. The intensity
of chest pain during balloon inflation was assessed on Borg’s
numerical scale (1–10) immediately after balloon deflation
(20). The precordial lead that provided the largest R wave
deflection was chosen for on-line electrocardiogram (ECG)
monitoring.
Coronary anatomy. Coronary angiography in at least four
projections with cranial and caudal angulated views was per-
formed before the angioplasty; the view with the best visual-
ization of the lesion was selected and the severity of the
coronary artery stenosis was measured using the stenosis
diameter program included in the Philips DCI S System. The
presence of collateral flow was graded according to Cohen and
Rentrop (21).
Heart rate and blood pressure data acquisition and anal-
ysis. Continuous ECG and blood pressure recordings were
made during phenylephrine testing and immediately before
and during the first 2-min balloon inflation (Fig. 1). All data
acquisition and analyses were performed by a method previ-
ously described in detail using a menu-driven software package
(CAFTS, Medikro Oy, Kuopio, Finland) (11,18). The RR
intervals were collected from the surface ECG and arterial
pressure was measured from the femoral artery using external
transducers. Stationary regions, excluding ectopic beats, were
selected for the analysis of heart rate, heart rate variability and
blood pressure. The baseline data were analyzed from a region
of approximately 60 s just before the first 2-min occlusion, and
a similar region at the end of the first 2-min balloon occlusion
was selected for occlusion data. The root-mean-square of the
differences between successive RR intervals was calculated
using standard equations. Heart rate and blood pressure
reactions during the first coronary occlusion were classified
according to an earlier control group (18).
Phenylephrine testing. The baseline phenylephrine test
was done after coronary angiography, 5 to 10 min before the
Abbreviations and Acronyms
BRS 5 baroreflex sensitivity
TIMI 5 thrombolysis myocardial infarction
Table 1. Clinical Data, Cardiovascular Medications at the Time of
the Angioplasty and Angiographic Characteristics of the Study
Group (47 Patients)
Age (years) 57 6 10
Hypertension 11 (23%)
History of chest pain (months) 14 6 21
Diabetes 4 (9%)
Beta-blocker 25 (53%)
Calcium antagonist 6 (13%)
Long-acting nitrate 33 (70%)
Stenosis severity (%) 84 6 8
Occluded artery
Left anterior descending 33 (70%)
Left circumflex 10 (21%)
Right coronary 4 (9%)
Visible collaterals 5 (10%)
Heart rate (beats/min) 69 6 13
Systolic blood pressure (mm Hg) 146 6 30
Diastolic blood pressure (mm Hg) 81 6 12
Occlusion time(s) 114 6 14
Chest pain 41 (87%)
ST changes 28 (60%)
Data presented are mean value 6 SD or number (%) of patients.
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first coronary occlusion. A 150-mg bolus of phenylephrine
was injected intravenously via a peripheral vein. The base-
line test was repeated in two cases with a phenylephrine
bolus of 200 mg to achieve a rise in systolic pressure
$15 mm Hg. The phenylephrine test was repeated during
the second coronary occlusion. The last phenylephrine dose
used in the baseline study was given after 30 to 60 s of
coronary occlusion. The slope of the linear relationship
between the length of RR interval (in ms) and the preceding
systolic pressure value (in mm Hg) from the analysis window
(that is, from the beat which started the sustained rise in
systolic pressure to the beat after the maximal pressure
elevation) was calculated by the CAFTS software using
linear least-mean-squares fitting to obtain baroreflex slope
(22) (Fig. 1). Only the slopes with statistically significant
(p , 0.05) positive associations between RR intervals and
preceding systolic pressures were accepted.
Statistical analysis. All analyses were performed using
the SPSS for Windows, Release 6.0, and data are presented
as mean 6 SD. Nonparametric Wilcoxon test was used for
intragroup comparisons. Categorical variables were com-
pared using the chi-square test and Fisher’s exact test. The
Mann–Whitney test was used for the comparison of contin-
uous variables. Linear regression analysis was used to assess
predictors of BRS, and stepwise logistic regression analysis
was employed to assess the independent predictors of loss of
integrity of arterial baroreflex during coronary occlusion.
Results
Heart rate, blood pressure and heart rate variability.
There were no significant changes in the mean values of
systolic blood pressure, heart rate and the root-mean-square of
the differences between successive RR intervals during the first
2-min coronary occlusion, but diastolic blood pressure and
standard deviation of RR intervals increased during the occlu-
sion (p , 0.05 for both). When the individual responses were
compared to an earlier control group (18), a marked brady-
cardic reaction ($8 beats/min) occurred in six women and was
accompanied by a hypotensive reaction—that is, .17 mm Hg
drop in mean systolic blood pressure—in three cases. Hypo-
tensive reactions occurred in two additional patients (1 wom-
Figure 1. Computer output of beat-to-beat RR intervals and invasive
systolic blood pressure (SAP) during phenylephrine tests in the
baseline (left upper panel) and during balloon occlusion (right upper
panel) of a 90% stenosis in left anterior descending coronary artery in
a 58-year-old male patient. The lower panels show respective barore-
flex slopes derived from the time windows shown by broken vertical
lines in the upper panels. In this case, coronary occlusion (hatched
bars, right upper panel) causes a mild, progressive bradycardia already
before the phenylephrine bolus. Phenylephrine bolus (150 mg) causes
a rise in systolic blood pressure, but at the end of the coronary
occlusion RR intervals suddenly shorten despite continuing pressure
rise. Baroreflex sensitivity could not be calculated because of the loss
of linear relationship between the RR intervals and the preceding
systolic blood pressure values despite adequate blood pressure reac-
tion during coronary occlusion in 13 patients.
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an). A tachycardic reaction ($8 beats/min) was observed in
one man and one woman and was accompanied by a hyper-
tensive reaction (.23 mm Hg) in the woman. Two other
patients (1 woman) had a hypertensive reaction without signif-
icant heart rate change.
Phenylephrine testing. The same phenylephrine dose in-
creased systolic pressure less during than before coronary
artery occlusion (21 6 21 vs. 36 6 16 mm Hg, p , 0.0001)
(Table 2). In six patients, phenylephrine failed to prevent the
coronary occlusion-induced reduction in systolic pressure. In
four of these patients, the fall in systolic blood pressure was
associated with paradoxical bradycardia (Fig. 2), and in two
cases no significant heart changes were observed. Because of
the loss of arterial baroreceptor-mediated heart rate control,
BRS could not be calculated during the occlusion in these six
patients.
Another major finding of the study was the significant
coronary occlusion-induced weakening of the linear relation-
ship between RR intervals and preceding systolic pressures
after phenylephrine injections. Hence, the average correlation
coefficient of the baroreflex regression decreased from 0.81 6
0.27 to 0.47 6 0.44 (p , 0.0001) during coronary artery
occlusion in the 41 patients with systolic pressure rises after
both phenylephrine tests (minimum 12 mm Hg during the
occlusion). In 13 of these patients, there was no significant
association between RR intervals and rising systolic pressures
during coronary occlusions. In 11 of these patients, the rise in
systolic pressure caused no change in heart rate, and in 2 cases,
the decrease in heart rate was inconsistent and started before
the phenylephrine bolus (Fig. 1). The correlation coefficient of
the baroreflex regression was inadequate in three patients
prior to coronary occlusion, and two of them developed
hypotension during the coronary occlusion; the third patient
had an inadequate correlation coefficient of the baroreflex
slope also during coronary occlusion.
Coronary occlusion reduced BRS from 5.2 6 3.8 to 4.1 6
3.5 mszmm Hg21 (p 5 0.01) in the 28 patients with preserved
arterial baroreceptor control of heart rate—that is, adequate
pressure response and correlation coefficient of the baroreflex
slope also during the coronary occlusion. The mean estimated
BRS during the coronary occlusion would have been 0.5
mszmm Hg21 in the 13 patients excluded owing to inadequate
correlation coefficients (Fig. 1) and 23.5 mszmm Hg21 in the
six patients excluded because of a paradoxical fall in systolic
pressure (Fig. 2).
Determinants of arterial baroreflex control. In linear re-
gression analysis, age was the only independent predictor of
BRS both in baseline (b 5 20.23, p , 0.001, n 5 44) and
during the coronary occlusion (b 5 20.39, p , 0.05, n 5 28).
The BRS was not related to the phenylephrine-induced pres-
sure rise either at baseline (r 5 20.08) or during coronary
occlusion (r 5 0.03, n 5 28), and the pressure rise in the 28
patients was only slightly lower during the coronary occlusion
than in the baseline (28.5 6 17.6 vs. 35.6 6 11.9 mm Hg (p 5
0.05). Loss of arterial baroreflex control of heart rate—that is,
fall in systolic pressure with no tachycardia or loss of statistical
association between RR intervals and preceding systolic pres-
sures—occurred in 19 patients during coronary occlusion. This
phenomenon occurred in all five patients who developed
hypotensive reactions during the first coronary occlusion (p ,
0.01) and was also predicted in univariate analysis by female
gender (p , 0.05) and advanced age (p , 0.05) (Table 3). In
stepwise logistic regression analysis, the only independent
predictor of the loss of arterial baroreflex control was ad-
vanced age (p , 0.05). The site (anterior vs. inferior) of
coronary occlusion did not predict BRS or any of the changes
of baroreflex function (Table 3).
Control group. A control group of 11 patients was assessed
to evaluate possible nonspecific changes in arterial baroreflex
function that might occur during balloon inflation in a chronic
total occlusion of a coronary artery. No significant changes in
BRS (from 5.3 6 4.0 to 5.2 6 3.7 mszmm Hg21), correlation
coefficient of baroreflex slope (from 0.69 6 0.34 to 0.73 6 0.35)
or phenylephrine-induced pressure rise (29 6 12 to 30 6
11 mm Hg) occurred.
Discussion
Our study documents impairment of human baroreflex
control during acute myocardial ischemia caused by occlusion
of a coronary artery. Baroreflex-mediated RR interval in-
creases during phenylephrine-induced elevations of arterial
pressure are attenuated, and the correlation between the RR
interval and blood pressure changes during the pressure rise
often weakens or becomes insignificant during the occlusion.
Of interest, acute myocardial ischemia also reduces the
Table 2. Comparison of Phenylephrine Tests in the Baseline and During Coronary Occlusion
Baseline Occlusion p Value
RR interval before phenylephrine (ms) 879 6 147 895 6 139 NS
Systolic blood pressure before phenylephrine (mm Hg) 136 6 26 145 6 30 ,0.05
Rise in systolic blood pressure after phenylephrine 36 6 16 21 6 21 ,0.0001
Correlation coefficient of slope* 0.81 6 0.27 0.47 6 0.44 ,0.0001
Baroreflex sensitivity (mszmm Hg21)† 5.2 6 3.8 4.1 6 3.5 0.01
Values are mean 6 SD. * 5 Data on 41 patients with adequate blood pressure rise after both phenylephrine
injections; † 5 data on 28 patients with adequate pressure rise and correlation coefficient of the baroreflex slope after
both phenylephrine injections.
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phenylephrine-induced arterial pressure elevations during cor-
onary occlusion.
Earlier studies. Our findings agree with those of earlier
animal studies showing that coronary occlusion causes marked
impairment of baroreflex control of the circulation (1–5).
There is, however, limited information on the effect of coro-
nary occlusion on human baroreflexes. Earlier clinical studies
showed that baroreflex control of heart rate is attenuated
during the early days of acute myocardial infarction (6–8).
Pomidossi et al. (9) measured BRS in 20 patients by giving
bolus injections of nitroglycerin during and after ;10-min
episodes of asymptomatic and symptomatic myocardial isch-
emia and observed smaller RR interval shortenings during
than after the ST segment depressions. Our study extends
these earlier works in several ways and is the first to focus on
the pathophysiology of arterial baroreflex during the initial
phase of abrupt coronary occlusion, a critical period for
out-of-hospital sudden death.
Background for impairment of baroreflex control of heart
rate. Although we have no certain information regarding the
mechanisms responsible for our findings, earlier animal re-
search provides helpful clues. Occlusion of a coronary artery
abruptly increases firing of nonmedullated vagal afferent fibers,
excites efferent cardiac vagal neurons and inhibits efferent
sympathetic activity (1,23–26). Acute myocardial ischemia can
also excite cardiac sympathetic afferent nerves, and recipro-
cally inhibit efferent cardiac vagal nerve activity and increase
efferent sympathetic activity (27,28). Inferential evidence from
humans points more to stimulation of afferent vagal than
sympathetic fibers during the early stages of abrupt coronary
occlusion regardless of the site of the occlusion (11,12).
Numerous experimental studies have shown that excitation of
cardiac vagal afferent fibers exerts a profound inhibitory
influence on the carotid baroreflex (1,2,25,29), and there is also
evidence that sympathetic afferent activity interferes with vagal
arterial baroreflex (30). Whatever mechanism is responsible,
the most likely explanation for arterial baroreflex impairment
during coronary occlusion is increased traffic carried over
afferent cardiac nerves. This explanation does not exclude
possible contributions from afferent cardiac nerve fibers sec-
ondary to distension of cardiac chambers due to increases of
preload (31).
Other potential mechanisms that might contribute to the
Figure 2. Computer output of beat-to-beat RR intervals and invasive
systolic blood pressure (SAP) during phenylephrine tests in the
baseline (left upper panel) and during balloon occlusion (right upper
panel) of a 67% stenosis in left anterior descending coronary artery in
a 62-year-old female patient. The lower panels show respective barore-
flex slopes derived from the time windows shown by broken vertical
lines in the upper panels. During coronary occlusion, the blood
pressure falls despite the same phenylephrine dose (150 mg) as in the
baseline test and the fall is accompanied by a paradoxical, progressive
bradycardia. The resulting baroreflex slope would have been negative,
but because of the loss of positive statistical correlation between the
RR intervals and preceding systolic pressures these cases (n 5 6) were
excluded from the statistical analysis of correlation coefficients and
baroreflex slopes. Coronary occlusion is shown by hatched bars (right
upper panel). Note the differences in the time scales and RR interval
scales in the recordings.
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attenuation of baroreflex function include ischemia-induced
blood pressure changes. Blood pressure levels were slightly
higher during coronary occlusion (Table 2), but saturation of
the baroreflex due to a high blood pressure level is unlikely to
be responsible for the attenuation. Systolic pressures were still
in the range where human baroreflex slopes are reported to be
linear (32), and the impairment we documented was unrelated
to the blood pressure level. In accordance with earlier experi-
ence (33), this study showed no relation between BRS and
degree of phenylephrine-induced pressure rise. Similarly, the
changes of baroreflex function are unlikely to be a nonspecific
phenomenon related to coronary angioplasty, because the
intracoronary balloon inflation protocol without myocardial
ischemia in the control group was not associated with changes
of baroreflex function. Complex interactions between
a-adrenergic stimulation and high efferent vagal activity at the
pre- and postsynaptic levels of the sinus node may also
contribute to the observed unstable behavior of heart rate in
response to the phenylephrine-induced pressure rises during
myocardial ischemia (34).
Blood pressure reactions during myocardial ischemia.
During arterial hypotension, unloading of arterial and cardio-
pulmonary baroreceptors should increase sympathetic nerve
activity and cause peripheral vasoconstriction. In contrast,
when hypotension accompanies acute myocardial ischemia,
increased stimulation of cardiac vagal afferents may inhibit the
arterial baroreflex and even override the arterial baroreceptor
reflex, resulting in peripheral vasodilatation and increased
cardiac vagal efferent activity, despite a reduction in arterial
blood pressure (1,2,24,25). The present study shows that such
reflex hypotension also occurs in humans despite a-stimulation
by phenylephrine, and that baroreflex slopes would become
paradoxically negative in these cases because of the concomi-
tant bradycardic reaction (Fig. 2). This type of reaction may
occur both during anterior and inferior wall ischemia, contrary
to the prevalent belief that vagal activation mainly occurs
during inferior myocardial ischemia. Reduction in the respon-
siveness to a-adrenergic stimulation—that is, diminished
phenylephrine-induced blood pressure rise—is in agreement
with earlier animal experiments (1).
Methodological considerations. We quantitated baroreflex
gain with the phenylephrine technique because this method is
the “gold standard” (34) and has been used to obtain prognos-
tic information on patients (35,36). Balloon occlusion of a
coronary artery is a widely used model for controlled myocar-
dial ischemia, but it fails to mimic natural circumstances in
many respects. For ethical reasons, the occlusion time was
limited here to a maximum of 2 min; therefore, our results
describe only the initial changes of baroreflex function during
the coronary occlusion.
Clinical significance of impaired baroreflex control.
Abrupt occlusion of a coronary artery is a major cause of
sudden cardiac death (13). Experimental studies have shown
that augmented parasympathetic activity has protective and
antifibrillatory effects during acute myocardial ischemia (14–
16,37,38). Similarly, low BRS during myocardial ischemia is a
predictor of vulnerability to fatal ventricular arrhythmia during
experimental coronary occlusion and after myocardial infarc-
tion (14–16,35–38). The present study shows that the afferent
signals from the ischemic myocardium have a greater signifi-
cance than do those from the arterial baroreceptors in the
modulation of vagal cardiac efferent activity and also periph-
eral vascular tone. This interference may be physiologically
advantageous and limit cardiac sympathetic outflow induced by
hypotension and baroreceptor withdrawal, but it may some-
times lead to severe hemodynamic instability. The clinical
significance of impairment of arterial baroreflex regulation
during acute coronary events merits further investigation.
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